de Seze, J <br/><br/>
Effect of glatiramer acetate (Copaxone) given orally in human patients: interleukin-10 production during a phase 1 trial.  [electronic resource] 

 -  Annals of neurology  May 2000 
 - 686 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Letter; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0364-5134 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--pharmacology<br/>Administration, Oral<br/>Cytokines--biosynthesis<br/>Double-Blind Method<br/>Glatiramer Acetate<br/>Humans<br/>Interleukin-10--biosynthesis<br/>Multiple Sclerosis--drug therapy<br/>Peptides--pharmacology